The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients

The lack of knowledge of the accurate conversion ratio (CR) between intravenous (IV) and oral hydromorphone and opioid rotation ratio (ORR) between IV hydromorphone and oral morphine equivalent daily dose (MEDD) may lead to poorly controlled pain or overdosing in cancer inpatients. We aimed to deter...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of pain and symptom management 2017-09, Vol.54 (3), p.280-288
Hauptverfasser:	Reddy, Akhila, Vidal, Marieberta, Stephen, Saneese, Baumgartner, Karen, Dost, Sara, Nguyen, Ann, Heung, Yvonne, Kwan, Simeon, Wong, Angelique, Pangemanan, Imelda, Azhar, Ahsan, Tayjasanant, Supakarn, Rodriguez, Edenmae, Waletich, Jessica, Lim, Kyu-Hyoung, Wu, Jimin, Liu, Diane, Williams, Janet, Yennurajalingam, Sriram, Bruera, Eduardo
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravenous Administration, Oral Adult Aged Aged, 80 and over Analgesics, Opioid - administration & dosage Analgesics, Opioid - pharmacokinetics Cancer cancer pain Cancer Pain - drug therapy Cancer patients Conversion conversion ratio Dosage Drug Dosage Calculations Female Hospitalization Humans Hydromorphone Hydromorphone - administration & dosage Hydromorphone - pharmacokinetics intravenous hydromorphone Linear Models Male Middle Aged Morphine Morphine - administration & dosage Morphine - pharmacokinetics morphine equivalent daily dose Narcotics opioid rotation Opioids Oral cancer Oxycodone - administration & dosage Oxycodone - pharmacokinetics Pain Palliative Care Patient Discharge Patients Readmission Regression analysis Retrospective Studies Rotation Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!